Clinical Trial Update: A Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer. [Phase 1, Phase 2]

View source ↗

Summary

The clinical trial update reports termination of the Phase 1/2 study of ONCT-534 in metastatic castration-resistant prostate cancer, and results have been poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• ONCT-534

Snippet

Sponsor: Oncternal Therapeutics, Inc | Conditions: Metastatic Castration-resistant Prostate Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-12-11